1. Home
  2. LSCC vs ABVX Comparison

LSCC vs ABVX Comparison

Compare LSCC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

HOLD

Current Price

$85.31

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$116.79

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSCC
ABVX
Founded
1983
2013
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.0B
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
LSCC
ABVX
Price
$85.31
$116.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
11
Target Price
$80.82
$130.09
AVG Volume (30 Days)
1.5M
2.0M
Earning Date
02-09-2026
08-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$494,889,000.00
$6,231,374.00
Revenue This Year
$4.26
$6.80
Revenue Next Year
$21.43
N/A
P/E Ratio
$429.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.69
$4.77
52 Week High
$89.47
$148.83

Technical Indicators

Market Signals
Indicator
LSCC
ABVX
Relative Strength Index (RSI) 63.70 45.31
Support Level $81.49 $108.95
Resistance Level $85.67 $129.64
Average True Range (ATR) 3.09 8.89
MACD 0.50 -1.97
Stochastic Oscillator 72.04 20.59

Price Performance

Historical Comparison
LSCC
ABVX

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: